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ABSTRACT 
The aim of this study was to investigate the antinociceptive potential of warm black tea brew of Camellia sinensis (L.) O. Kuntze (Theaceae). 
This was tested in rats using high grown Sri Lankan Dust grade No: 1 black tea and four models of noceiception (tail flick, hot plate, 
writhing and formalin tests). Four doses of black tea brew (BTB) 84, 167, 501, 1336 mg/ml was made and orally administed to rats (N = 
9/group) for testing purposes. The results showed that strong BTB possesses marked and significant (P < 0.05) antinociceptive activity 
having a rapid onset and a short duration of action. Further, the BTB also had profound and significant (P < 0.05) antihyperalgesic activity 
(in terms of carrageenan induced thermal hyperalgesic test and formalin test), in vitro antioxidant activity (DPPH method) and antihistamine 
activity  (in terms  of  wheal  test).  The  BTB-induced  antinociception  was  blocked  by  nalaxone  but not  by  atropine or  metachlopramide 
indicating opioid receptor mediation. Further, even with subchronic administration of BTB, tolerance was not developed. It is concluded that 
BTB of C. sinensis has mild to moderate oral antinociceptive activity with swift onset and short duration of action which is mediated via 
opioid, antioxidant and antihistamine mechanisms. 
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INTRODUCTION 
Camellia  sinensis  (L.)  O.Kuntze  (Theaceae)  popularly 
known, as the tea plant is an evergreen shrub or tree with 
leaves 5-9 x 2-2 cm, obtuse or short rounded points
1. It is 
native to Southeast Asia and is extensively cultivated in 
countries  like  India,  Java,  China,  Japan,  Bangladesh, 
Indonesia, Kenya, and Turkey  for manufacture of tea
2. 
Tea  is  produced  from  freshly  harvested  tender  shoots, 
comprising two or three of the topmost immature leaves 
and the bud of Camellia sinensis plant.  Depending on 
the manufacturing technique there are three types of teas: 
black tea (fully aerated or fermented), green (unaerated 
or  unfermented)  and  oolong  (partially  aerated  or  semi 
fermented). 
Phytochemically  black  tea  contains  flavonoids 
(catechins, theaflavins, thearubigins, flavonols), caffeine, 
amino  acids  including  theanine,  peptides,  sugars, 
potassium, volatiles and vitamins
2. 
Several  scientific  studies  have  indicated  that  tea 
drinking,  particularly,  the  green  teas,  provide  many 
health  benefits:  promotion  of  cardiovascular  health; 
antioxidative;  antiaging;  anticarcinogenic;  anti-
inflammatory; antidiabetic; antibacterial; central nervous 
system  stimulation;  promotion  of  oral  health 
2,3;  stress 
relieving
4 and anxiolytic
5; diuretic
6. On the other hand, 
there are several traditional health claims for tea such as 
improving  of  blood  flow,  elimination  of  alcohol  and 
toxins, clearance of urine and improvement of its flow, 
relieving  of  joint  pains,  improvement  of  resistance  to 
diseases
7.  According  to  Sri  Lankan  folkoric  and 
traditional medicine strong black tea has pain relieving 
properties and often recommended for day-to-day body 
aches and pains, and joint pains. In addition, it is clamed 
to have diuretic action
8 and this has been scientifically 
proven
6.However,  pain  killing  property  of  tea  has  not 
been  validated  by  scientifically  conducted 
experimentations. 
The aim of this study was to examine the antinociceptive 
potential of black tea. This was investigated in rats using 
high grown Sri Lankan Dust grade No: 1 black tea. The 
Dust grade was selected, as it is most widely consumed 
by  Sri  Lankan  tea  drinkers  probably  because  of  its 
comparatively low price, easy availability and flavour. 
MATERIALS AND METHODS 
Experimental animals 
Healthy adults Wistar male rats (weight: 200-250 g) and 
female rats (weight: 175-200 g), and male mice of ICR 
strain  (weight:  35-40g)  purchased  from  the  Medical 
Research  Institute  Boralla,  Sri  Lanka  were  used.  The 
animals  were  kept  under  standardized  animal  house 
conditions (photoperiod: approximately 12h natural light 
per  day;  temperature:  28-30 
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55%)  with  free  access  to  tap  water  and  pelleted  food 
(Master  Feed  Ltd.,  Colombo,  Sri  Lanka).  All  animal 
experiments  were  conducted  in  accordance  with  the 
internationally accepted laboratory animal use and care, 
and guidelines (guiding principles in the use of animals 
in  toxicology,  adopted  by  the  society  of  toxicology  in 
1999) and rules of the Department of Zoology, Faculty 
of  Science,  University  of  Colombo,  for  animal 
experimentations.  
Manufacture of tea samples 
The black tea belonging to the grade of Dust No 1 was 
manufactured at St. Coombs estate tea factory of the Tea 
Research Institute, Talawakelle, Sri Lanka, with its own 
green leaves (1382 m above mean sea level) using the 
orthodox- rotorvane manufacture technique. Tea samples 
was packed in triple laminated, aluminum foil bags, (1 
kg each) and stored at –20 
0C until use. The C. sinensis 
leaves  used  to  manufacture the  black  tea  samples  was 
identified  and  authenticated  by  Professor  (Mrs.)  A.S. 
Senaviratna, Department of Plant Science, University of 
Colombo.  A  voucher  specimen  (wdr/tspf  200)  was 
deposited at the museum of the Department of Zoology 
University of Colombo. 
Preparation of Black tea brew (BTB) 
Black tea brew (BTB) was made according to the ISO 
standards 
9: adding 2g of black tea to 100 ml of boiling 
water and brewing for 5 min. This contains 43.7% (w/w) 
tea  solids  in  water.  Based  on  this  data,  1336  mg/ml 
(equivalent to 24 cups, 1 cup = 170 ml) of BTB in 2 ml 
for oral administration was made by adding 8g black tea 
to 15 ml boiling water and brewing for 5 min.501 mg/ml 
(equivalent to 9 cups), 167 mg/ml (equivalent to 3 cups) 
and 84 mg/ml (equivalent to 1.5 cups) concentrations of 
BTB  were  then  made  by  diluting  appropriately  with 
boiling water.  
Evaluation of antinociceptive activity using tail flick 
test 
This was performed as described by Langerman et al 
10. 
Fifty four male rats were randomly divided in to 6 equal 
groups (N = 9/ group) and were orally treated with the 
BTB  in  the  following  manner:  group  1  with  2  ml  of 
water; group 2 with 84 mg/ml dose of BTB; group 3 with 
167 mg/ml dose of BTB; group 4 with 501 mg/ml dose 
of  BTB;  group  5  with  1336  mg/ml  dose of  BTB;  and 
group 6 with reference drug aspirin (133.5 mg/kg). Two 
to  three  hours  before  treatment  and  then  at  hourly 
intervals for 6h post treatment these rats were subjected 
to tail flick test by immersing their tails (5-6 cm from the 
tip) in a water bath at 55 
0C and the time taken to flick 
the tails (the reaction time) was noted. A cut off time of 
10 s was used to avoid tissue damage. 
Evaluation of antinociceptive activity using hot plate 
test 
Fifty four male rats were randomly assigned into 6 equal 
group  (N  =  9/  group)  and  were  orally  treated  in  the 
following manner: group 1 with 2 ml of water; group 2 
with 84 mg/ml dose of BTB; group 3 with 167 mg/ml 
dose of  BTB;  group  4  with  501  mg/ml  dose  of  BTB; 
group 5 with 1336 mg/ml dose of BTB; and group 6 with 
reference drug aspirin (133.5 mg/kg). Two to three hours 
before treatment and then at hourly intervals for 6h (post 
treatment)  these  rats  were  placed  on  an  enclosed  hot 
plate (Model MK 35A, Maroma Co. Ltd., Tokyo, Japan) 
at 50 
0C and the time taken (reaction time) to lick either 
hind  paw  or  jump  up  was  recorded  as  described  by 
Langerman et al 
10. A cut off time of 20 s was used to 
avoid tissue damage. 
Evaluation of antinociceptive activity using formalin 
test 
This was performed essentially as described by Farsam 
et al 
11. Fifty four male rats were randomly assigned into 
6 equal groups (N = 9/group) and were orally treated in 
the following manner: group 1 with 2 ml of water; group 
2 with 84 mg/ml dose of BTB; group 3 with 167 mg/ml 
dose of  BTB;  group  4  with  501  mg/ml  dose  of  BTB; 
group 5 with 1336 mg/ml dose of BTB; and group 6 with 
reference  drug  aspirin  (133.5  mg/kg).  One  hour  after 
administration,  each  rat  was  injected  with  0.05  ml  of 
2.5%  formalin  solution  (BDH  chemicals,  Poole,  UK) 
into  subplanter  surface  of  the  left  hind  paw.  The  rats 
were  then  observed  for  60  min  and  the  numbers  of 
flinching,  lifting  and  licking  and  the  cumulative  time 
spent on lifting and licking were recorded in two phases: 
early phase 1-5 min and late phase 15-60 min. The time 
per lift and lick were then computed. 
Evaluation  of  antinociceptive  activity  using  acetic 
acid-induced writhing test 
Forty  five  mice  were  randomly  divided  into  5  equal 
groups  (N  =  9/group)  and  were  orally  treated  in  the 
following manner: group 1 with 2 ml of water; group 2 
with 84 mg/ml dose of BTB; group 3 with 167 mg/ml 
dose of  BTB;  group  4  with  501  mg/ml  dose  of  BTB; 
group 5 with 1336 mg/ml dose of BTB; and group 6 with 
reference drug aspirin (133.5 mg/kg). One hour later, 0.5 
ml of 10% acetic acid was injected intraperitoneally to 
each of these mice and number of writhings (abdominal 
contractions and stretches) that occurred between 5- 20 
min were counted and recorded as described by  Ojewole 
12. 
Evaluation of antihyperalgesic activity 
This was performed as described by Richardson et al 
13. 
Thirty six male rats were randomly assigned into 4 equal 
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following manner: group 1 with 2 ml of water; group 2 
with 84 mg/ml dose of BTB; group 3 with 167 mg/ml 
dose of BTB; and group 4 with 501 mg/ml dose of BTB. 
Immediately afterwards, these rats were subcutaneously 
injected with 0.05 ml of 1% carregeenan suspension in 
normal saline into the planter surface of the left hind paw 
to induce pain. These rats were subjected to hot plate test 
at hourly intervals for 6h as described previously and the 
reaction time was determined. 
Investigation  of  development  of  tolerance  to  BTB 
with chronic administration on hot plate test 
Eighteen  rats  were  randomly  assigned  into  two  equal 
group (N = 9/group). One group was orally administered 
with 2ml of water daily for 43 consecutive days and the 
other with the 501 mg/ml dose of BTB. These rats were 
subjected  to  hot  plate  test  as  described  previously  1h 
following  treatment  on  days  1,  15,  29,  and  43  of 
treatment and the reaction time was determined. 
Evaluation  of  effects  of  BTB  on  nervous  co-
ordination, muscle strength and rectal temperature 
Eighteen  rats  were  randomly  divided  into  two  equal 
group (N = 9/ group). One group was orally treated with 
2 ml of water and the other with the 501 mg/ml dose of 
BTB. One hour later, these rats were subjected to Bridge 
test 
14 and Righting reflex test 
15 (to investigate its effect 
on  nervous  co-ordination),  and  Bar  test 
14  (for muscle 
strength)  and  their  respective  latencies  were  recorded. 
Immediately  following  this  their  rectal  temperatures 
were  determined  using  a  digital  thermometer  (TM  -II, 
Focal Corporation, Tokyo, Japan). 
Investigation  of  involvement  of  opioid  receptor 
mediation  
Twelve  rats  were  divided  into  two  groups.  Those  in-
group  1  (N  =  6)  were  subcutaneously  injected  with  5 
mg/kg nalaxone (an opioid receptor antagonist) and those 
in group 2 (N = 6) with isotonic saline. After 45 min, rats 
in both groups were orally administered with 2 ml of 501 
mg/ml dose of BTB. These rats were subjected to the hot 
plate test before treatment and 1 h after BTB treatment 
and the reaction time was determined 
16. 
Involvement of dopamine receptor mediation 
Twelve  rats  were  randomly  divided  into  two  equal 
groups.  The  rats  in  group  1  (N  =  6)  were  orally 
administered  with  1.5  mg/kg  of  metachlopramide,  a 
dopamine D2 antagonist, in 1ml of methylcellulose. The 
rats in group 2 (N = 6) were orally treated with 1 ml of 
methylcellulose. After 60 min both groups of rats were 
orally treated with the 501 mg/ml dose of BTB. These 
rats were subjected to hot plate test before treatment and 
1  h  after  BTB  treatment  and  the  reaction  time  was 
determined 
16. 
Investigation  of  involvement  of  muscarinic  receptor 
mediation 
Twelve  rats  were  randomly  divided  into  two  equal 
groups. Those in group 1 (N= 6) were intraperitoneally 
injected with 5 mg/kg of atropine salphate, a muscarinic 
receptor antagonist, and those in group 2 (N = 6) with 
isotonic  saline.  After  10  min,  the  rats  in  both  groups 
were  orally  administered  with  the  501  mg/ml  dose  of 
BTB.  One  hour  later, these  rats  were  subjected to  hot 
plate test, before treatment and 1 h post treatment with 
BTB and reaction time was determined 
17. 
Investigation of sedative activity 
Twelve  rats  were  randomly  divided  into  two  equal 
groups. One group (N = 6) was orally treated with the 
501 mg/ml dose of BTB and other group (N = 6) treated 
with 2 ml of water. After 1 h, each rat was placed in the 
center of the rat hole-board and observed  for 7.5 min. 
The  number  of  rears,  number  of  head  dips  and 
locomotary activity were recorded as described by File 
and Wardill 
18. Time per head dip was then computed. 
Evaluation of antihistamine activity 
Eighteen  rats  were  randomly  assigned  into  two  equal 
group (N = 9/ group). The left posterior lateral side of 
their skin was clearly shaved under aseptic conditions. 
One group was orally treated with the 501 mg/ml dose of 
BTB and the other with 2 ml water. After 1 h, 50 µl of 
200  µg/  ml  of  histamine  in  normal  saline  was 
subcutaneously  injected to the  shaved  area of  the  skin 
and the area of the wheal formed was determined after 
1.5 min 
19. 
Effect on membrane stabilization 
This  activity  was  evaluated  using  heat-induced 
haemolysis of rat erythrocytes in vitro as described by 
Dharmasiri et al 
20. Vials containing 20 µl fresh rat blood 
in  1  ml  of  phosphate  buffered  saline  were  treated  in 
triplicate with the BTB so that the final concentrations of 
the tea brew in the vials were 2.5, 5, 10 and 20 mg/ml. 
Fifteen microliter of saline was used as the control. The 
vials were then incubated for 15 min at 37 
0C followed 
by 54 
0C for 25 min, centrifuged at 3200 x g for 2 min 
and the absorbance of the supernatant was measured at 
540 nm using a spectrophotometer (Jasco V560, Jasco 
Corporation,  Tokyo,  Japan).  The  percent  inhibition  of 
haemolysis with respect to the controls was calculated.  
Evaluation of antioxidant activity (DPPH assay) 
This was done using 750 µl of freshly prepared 20ppm of 
1-1-diphenyl-2-picrylbhydrazyl  (DPPH)  solution  as 
described in detail by Abeywickrama et al 
21. Briefly, 3 
concentrations of BTB (84, 167, 501 mg/ml) types were 
made, and 750 µl of these samples were added to 750 µl 
of DPPH solution (in triplicate) and incubated at 30 
0C 
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using a spectrophotometer. The percentage of the DPPH 
radical scavenged by the tea extracts was calculated, and 
the  antioxidant  activity  was  expressed  as  the  Trolox 
equivalent in µgl
-1. 
Overt signs of toxicity 
All rats used in the tolerance study were closely observed 
for  2-3  h,  after  each  daily  administration  of  BTB  or 
vehicle  for  any  overt  signs  of  toxicity  (salivation, 
lachrymation,  ptosis,  stupor,  squinted  eyes,  teeth 
exposure,  writhings  convulsions,  tremors,  yellowing  of 
fur,  loss  of  hair  and  breathing  depressions),  stress 
(erection  of  fur  and  exopthalmic),  behavioural 
abnormalities  (such  as  impairment  of  spontaneous 
movements,  climbing,  cleaning  of  face  and 
autogrooming,  and  ataxia,  rolling  and  other  postureal 
changes) and aversive behaviours (biting and scratching 
behaviour,  licking  of  tail,  paws  and  penis,  intense 
grooming  behaviour  or  vocalization)  and  diarrhoea.  In 
addition,  the  rats  were  observed  for  the  presence  of 
‘Straubs’ tail reaction, and food and water intake. 
Statistical analysis 
Data  were  expressed  as  mean  ±  SEM.  Statistical 
comparison  were  made  using  one-way  ANOVA  with 
Turkey’s  family  error  post  hoc  test.  Comparison  of 
unpaired data was done by using Mann-Whitney U-test. 
Dose dependencies were determined by using Pearson’s 
correlation test. Significance level was set at P< 0.05. 
RESULTS 
Tail flick test 
As shown in Table 1, compared to control, all doses of 
BTB  tested,    significantly  (  P  <  0.05)  increased  (84 
mg/ml  dose  by  95%;  167  mg/ml  dose  by  25%;  501 
mg/ml  dose  by  21%;  1336  mg/ml  dose  by  31%)  the 
reaction time in the tail flick test at 6 h post-treatment. 
This effect was however, not dose-dependent (r
2 = 0.30; 
P  >  0.05).  In  addition,  moderate  but  significant  (P  < 
0.05) prolongations of the reaction time was evident with 
the 84 mg/ml dose at 5
th (by 50%), 501 mg/ml dose at 3
rd 
h (by 44%) and 1336 mg/ml dose at 2
nd h (by 26%) and 
4
th h (by 30%) post treatment. On the other hand, aspirin 
prolonged the reaction time at all time points from the 
2
nd h upto 6h (2
nd h by 12.5%, 3
rd h by 13%, 4
th h by 
20%, 5
th h by 31% and 6
th h by 57%). 
Hot plate test 
The  results  of  the  hot  plate  test  with  male  rats  are 
depicted in Table 2. As shown, 501 mg/ml (1
st h by 30% 
and 2
nd by 38%) and 1336 mg/ml (1
st h by 79% and 2
nd h 
by 38%) doses of BTB moderately and significantly (P < 
0.05) increased the reaction time at 1 and 2 h  of post 
treatment. The reference drug, aspirin significantly (P < 
0.05) increased the reaction time upto 4
th h (1
st h by 71%, 
2
nd h by 60%, 3
rd h by 42% and 4
th h by 21%). 
Formalin test 
Table 3 summarizes the results of the formalin test. As 
shown, none of the doses of BTB significantly (P > 0.05) 
altered  any  of  the  parameters  investigated  during  the 
early  phase  (0-5  min).  On  the  other  hand,  501  mg/ml 
dose (number flinchings by 58%; number of liftings by 
34%; number of lickings by 12.5%; time spent on lifting 
by 70%; time spent on licking by 49%; time per lift by 
70% and time per lick by 49%) and the 1336 mg/ml dose 
(number   of  flinchings  by  58%;  number  of  liftings  by 
34%; number of lickings by 12.5%; time spent on lifting 
by 70%; time spent on licking by 49%; time per lift by 
70% and time per lick by 49%) significantly (P < 0.05) 
suppressed  the  parameters  investigated  during  the  late 
phase  (20-60  min).  In  contrast,  aspirin,  the  reference 
drugs  significantly  (P  <  0.05)  inhibited  all  the  four 
parameters of this test at the second phase (number  of 
flinchings by 72%; number of liftings by 43%; number 
of lickings by 30%; time spent on lifting by 13%; time 
spent on licking by 50%). 
Writhing test 
As shown in Table 4 only the 501 mg/ml (by 35%) and 
the 1336 mg/ml (by 37%) doses of BTB significantly (P 
< 0.05) and markedly impaired the number of writhings. 
However, this effect was dose dependent (r
2 = 0.89; P < 
0.05).  The reference drug, dicolofenec significantly (P < 
0.05) and profoundly reduced (by 91%) the number of 
writhings. 
Anti-hyperalgesic activity 
As  shown  in  Table  5,  all  the  three  doses  of  BTB 
significantly (P < 0.05) increased the reaction time upto 
3h (1
st h, 84 mg/ml by 32 %; 167 mg/ml by 19 %; and 
501  mg/ml  by  17  %:  2
nd  h,  84  mg/ml  by  40  %;  167 
mg/ml by 22 %; 501 mg/ml by 10 %: 3
rd h, 84 mg/ml by 
23 %; 167 mg/ml by 19 %; and 501 mg/ml by 19 %). 
These effects were  inversely dose-related (1
st h, r
2 = - 
0.83, P < 0.05; 2
nd h, r
2 = - 0.77, P < 0.05 and 3
rd h r
2 = - 
0.75, P < 0.05). 
Investigation of development of tolerance 
Continuous  administration  of  the  501  mg/ml  dose  of 
BTB evoked a significant (P < 0.05) increase in reaction 
time on days 1 (control versus treatment: 10.90 ± 0.10 
versus 12.96 ± 0.10 s) day 15 (control versus treatment: 
10.50 ± 0.08 versus 12.60 ± 0.04 s) 29 (control versus 
treatment: 11.25 ± 0.05 versus 13.98 ± 0.03 s) and 43 
(control versus treatment: 11.80 ± 0.05 versus 13.40 ± 
0.06  s).  Further,  the  magnitude  of  the  response  was 
essentially similar in all the days tested. 
Muscle  co-ordination,  muscle  strength  and  rectal 
temperature 
The 501 mg/ml dose of BTB did not significantly (P > 
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(control versus treatment: 55.60 ± 0.83 versus 53.20 ± 
0.85  s)  or  the  righting  reflex  test  (control  versus 
treatment: 0.31 ± 0.001 versus 0.300 ± 0.001 s) or the 
rectal  temperature  (control  versus  treatment:  100.0  ± 
0.04 versus 100.70 ± 0.09 
0F). 
Opioid receptor mediation 
In  the  nalaxone  study,  with  the  hot  plate  technique, 
subcutaneous administration of nalaxone significantly (P 
< 0.05) impaired (by 14.3%) the reaction time induced 
by 501 mg/ml dose of BTB (501 mg/ml dose of BTB + 
saline versus 501 mg/ml dose of BTB + nalaxone: 14.0 ± 
0.46 versus 12.0 ± 0.36 s). 
Dopamine receptor mediation 
In  the  metachlopramide  study,  with  the  hot  plate 
technique,  the  oral  administration  of  metochlopramide 
did not significantly (P > 0.05) change the reaction time 
induced by the 501mg/ml dose of BTB (501 mg/ml dose 
of BTB + 1% methyl cellulose versus 501 mg/ml dose of 
BTB  +  metochlopramide:  9.75  ±  0.19  versus  10.66  ± 
0.30 s) 
Muscarinic receptor mediation 
In the atropine study, with the hot plate technique, the 
intraperitoneally  injection  of  atropine  did  not 
significantly (P > 0.05) alter the reaction time provoked 
by the  high dose of BTB (501  mg/ml dose of  BTB + 
water versus 501 mg/ml dose of BTB + atropine: 13.2 ± 
0.10 versus 13.4 ± 0.10 s). 
Sedative activity 
The 501 mg/ml dose of BTB significantly (P < 0.05) and 
moderately increased the locomotary activity (by 122 %; 
control versus treatment: 12.4 ± 0.4 versus 27.5 ± 0.4) 
and  the  number  of  rears  (by  75  %;  control  versus 
treatment: 14.6 ± 0.4 versus 25.6 ± 0.5). On the other 
hand, the number of head dips (control versus treatment: 
5.0  ±  0.02  versus  5.7  ±  0.1)  and  time  per  head  dip 
(control versus treatment: 1.2 ± 0.02 versus 1.0 ± 0.02) 
were not significantly (P > 0.05) altered. 
Antihistamine activity 
The  501  mg/ml  dose  of  BTB  significantly  (P  <  0.05) 
reduced (by 34 %) the area of the wheal  formed after 
injection of histamine (control versus treatment: 48.77 ± 
1.12 versus 32.44 ± 0.59 mm). 
Plasma membrane stabilization activity 
In  the  rat  heat  induced  haemolysis  test,  the  tested 
concentrations  of  the  BTB  failed  to  significantly  (P  > 
0.05) inhibit the haemolysis (data not shown). 
Antioxidant activity (DPPH assay) 
The antioxidant activity of tea samples are given in Table 
6. As shown, BTB exhibited dose-dependent (r
2 = 0.83, 
P < 0.05) antioxidant activity in vitro.  
 
 
Overt signs of toxicity 
Oral treatment of the 501 mg/ml dose of BTB did not 
induce  signs  of  overt  toxicity,  stress  or  aversive 
behaviors. Further, the BTB treatment did not produced 
Straubs tail reaction or suppressed food and water intake. 
DISCUSSION 
The results clearly demonstrate, for the  first time, that 
strong  tea  brew  of  C.  sinensis  made  from  Sri  Lankan 
high grown Dust grade No: 1 black tea possesses oral 
antinociceptive activity as evaluated from tail flick, hot 
plate, writhing and formalin algesiometric models, which 
are  scientifically  validated  and  widely  used  tests  to 
evaluate  potential  antinociceptive  agents.  The  positive 
results  in  the  first  two  tests  suggest  that  the  BTB  is 
effective against transient phasic pain which is centrally 
mediated both at spinal and supraspinal  levels: the tail 
flick  technique  predominately  measures  spinal  reflexes 
whilst the  hot  plate test  predominately  measures  supra 
spinal reflexes 
22. On the other hand, the positive result 
in the writhing test indicates that the BTB  is effective 
against peripheral and non specific pain of visceral origin 
23,  whilst  the  results  of  the  formalin  test  indicate  its 
effectiveness against peripheral continuous inflammatory 
pain (particularly the second phase) 
24. 
Overall, these were genuine and primary effects and not 
secondary manifestations springing from motor deficits 
(as reflected from bar test and undepressed locomotory 
activity  in  the  rat  hole-board  test),  nervous 
incoordination (as judged by righting reflex and Bridge 
tests) or hypothermia (in terms of rectal temperature). In 
addition,  the  results  show  that  the  BTB  has 
antihyperalgesic  activity  (as  judged  by  the  results  of 
carrageenan-induced  thermal  hyperalgesic  test  and  late 
phase  of  formalin  test).  Possessing  of  antinociception, 
especially,  against  continuous  inflammatory  pain  and 
antihyperalgesic  activity  of  rapid  onset  by  BTB  brew 
without development of tolerance are important features. 
Continuous  inflammatory  pain  is  one  of  the  most 
common  type  of  pathological  pain  in  clinical  practice 
and persistent pain is known to have a major impact on 
the quality of life 
25.  
The antinociceptive activity of the BTB had a rapid onset 
and a short duration of action. This is presumably due to 
rapid  absorption  and  equally  rapid  degradation  and/or 
equally  rapid  clearance  of  the  active  component’s. 
Alternatively, the short duration of action may be due to 
the formation of a metabolite which is antagonist to the 
production of antinociceptive effect 
26 . Having a rapid 
onset and a short duration of action of antinociception is 
some times useful in pain management strategies.  
Food  restriction  induces  antinociception  in  rats 
27  but 
such a mode of action is unlikely, as food was available Ratnasooriya Wanigasekara Daya et al. IRJP 2 (6) 2011 128-137 
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throughout the study period. Further, hypophagia was not 
apparent.  Stress  is  known  to  evoke  antinociception 
28. 
Antinociception  in  this  study  cannot  be  attributed  to 
stress, as there were no signs of exopthalmia, fur erection 
or  aversive  behaviours.  Further,  we  have  previously 
shown  that  BTB  is  anxiolytic 
5.  Membrane  stabilizers 
induce  antinociception  by  elevating  pain  threshold 
29. 
Such a mechanism is unlikely to be operative here as the 
BTB  failed to suppress heat-induced  haemolysis of rat 
erythrocytes 
20 and the early phase of the formalin test 
30. 
Sedation is known to impair pain 
31 and several sedatives 
possess  antinociceptive  activity 
29.  However,  the 
antinociceptive  activity  of  BTB  is  unlikely  to  be 
mediated via sedation as none of the parameters of the 
rat hole-board test was suppressed. Antinociception can 
be  mediated  via  cholinergic  and  dopaminergic 
mechanisms 
29.  However,  antinociception  elicited  by 
BTB  was  not  blocked  either  by  muscarinic  receptor 
antagonist,  atropine  or  dopamine  receptor  antagonist, 
metochlopramide.  Thus,  both  these  mechanisms  are 
unlikely  to  be  operative  here.  Tea  contains  caffeine 
2. 
But, it is doubtful that BTB induced antinociception is 
mediated via caffeine: although caffeine is incorporated 
in some compound analgesic preparations and is claimed 
to  enhance  the  analgesic  effect  this  is  not  proven 
conclusively 
32. 
On  the  other  hand,  nalaxone,  the  universal  opioid 
receptor antagonist, curtailed the antinociception induced 
by BTB indicating that antinociception is mediated via 
opioid mechanisms.  Importantly, the opioid receptor of 
rat is identical in structure and pharmacology to human 
receptors 
33  and  hence  this  result  is  likely  to  be 
applicable  to  man.  In  this  study,  there  was  a  lack  of 
typical µ-opioid receptor mediated side effects such as 
breathing depression, elicitation of Straubs tail reaction 
and sedation possibly suggesting binding and activation 
of  б-  and  k-  opioid  receptors  in  mediating  the 
antinociceptive  action 
33.  The  diminished  tail  flick 
response  compared  to  hot  plate  response  with  the 
treatment of BTB may provide additional support for this 
notion as µ-opioid receptors are the predominate type in 
the rat spinal cord 
33. The stimulation of opioid receptors 
by  tea  could  be  due  to  direct  agnostic  activities  of 
opioidiomimetic constituents in the brew and/or due to 
increase release of endogenous opioid peptides. After all, 
tea  brew  contains  a  variety  of  phyto  constituents 
2,  7. 
Further,  experiments  are  obviously  needed  for  the 
elucidation of these potential mechanisms. 
BTB suppressed the numbers of paw lickings, flinchings 
or liftings and,  licking and  lifting durations  in the  late 
phase of the formalin test. Pain induced in the late phase 
of  the  formalin  test  is  due  to  release  of  inflammatory 
mediators such as prostaglandins, histamine, serotonin or 
bradykinin  at  the  site  of  injection 
24.  BTB  has 
antihistamine  (wheal  test)  and  PG  synthesis  inhibiting 
activity 
34, 35, and thus could account for the inhibition of 
the  late  phase  of  the  formalin  test.  Opioids  can  also 
inhibit the late phase of this test 
24. This mode of action 
is also likely to be responsible as nalaxone blocked the 
BTB  induced  antinociception  in  the  hot  plate  test.  In 
addition, phenolic continuants of tea could also block the 
late phase of formalin test 
36. Prostaglandins are involved 
in the mediation of pain 
29 and prostaglandin synthesis 
blockers are widely used as analgesics 
29. BTB is shown 
to  possess  prostaglandin  synthesis  blocking  activity 
35 
and  inhibition  of  writhing  in  the  writhing  test  in  this 
study also supports this finding. Therefore this mode of 
action  too  could  play  a  substantial  role  inducing 
antinociception in this study.  
Free radicals are now implicated with pain 
37 and some 
plant  antioxidants  have  pain-alleviating  properties 
23. 
Dust grade tea had antioxidant activity (by DPPH assay) 
in agreement with others 
2, 21 and this action could also 
play an important role in inducing antinociception. This 
may be attributed to flavonols of the tea 
2, 7. Morphine, a 
well-known  opioid  agonist  was  also  proven  to possess 
antioxidant properties 
38. 
Nitric oxide is also now linked with pain 
33. Black tea is 
known to reduce nitric oxide production 
35, 39. Therefore, 
possibility exists that this mechanism could, at least, play 
an  auxiliary  role  in  inducing  antinociception  in  this 
study. 
Interestingly  even  with  daily  chronic  administration  of 
strong BTB, there were no overt signs of toxicity. Other 
studies  have shown  long term administration of strong 
BTB  does  not  produce  renal  (in  terms  of  serum 
creatinine, urea and Na
+, K
+ level) and hepatic (in terms 
of SGOT and SGPT and serum protein) toxicity 
40.  
One of the serious side effects of analgesics acting via 
inhibition  of  prostaglandin  synthesis  is  gastric 
haemorrahage  due  to  induction  of  gastric  leasions 
41. 
However, BTB in addition to its pain relieving action is 
shown  to  have  gastroprotective 
42  and  gastric  ulcer 
healing activity 
43. This is obviously a plus point for BTB 
as a antinociceptive agent. 
In conclusion, this study, showes for the first time, that 
strong black tea can act as safe orally active, short acting 
moderate  antinociceptive  agent  actively  via  multiple 
mechanisms. Consumption of strong BTB may be useful 
to  relieve  day-today  body  aches  and  pains.  Further, 
studies  are  however  warranted  before  firm 
recommendations are made. Ratnasooriya Wanigasekara Daya et al. IRJP 2 (6) 2011 128-137 
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Table 1: Effect of oral administration of Sri Lankan high grown Dust grade No 1 black tea brew (Camellia sinensis) on the reaction time of rats in the tail flick test 
(mean ±SEM) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* P< 0.05 compared to control (ANOVA with Turkey’s family error post hoc test) 
 
Table 2: Effect of oral administration of Sri Lankan high grown Dust grade No 1 black tea brew (Camellia sinensis) on the reaction time of rats in the hot plate test 
(mean ±SEM) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*P< 0.05 compared to control (ANOVA with Turkey’s family error post hoc test); BTB= Black tea brew 
 
 
 
  Reaction time (sec) 
Treatment  Pre 
treatment 
Post treatment 
   
1st hour  2nd hour  3rd hour  4th hour  5th hour  6th hour 
Control 
2 ml water 
 
2.62±0.60 
 
2.14±0.29 
 
1.67±0.39 
 
1.67±0.19 
 
1.44±0.14 
 
1.30±0.27 
 
1.02±0.11 
BTB               
84 mg/ml 
 
1.39±0.12  0.92±0.10  1.23±0.10  1.49±0.17  0.76±0.08  1.95±0.20*  1.99±0.19* 
167 mg/ml 
 
2.4±0.32  1.92±0.09  1.45±0.23  1.23±0.15  1.28±0.10  1.33±0.10  1.27±0.08* 
501 mg/ml 
 
0.69±0.05  1.14±0.17  0.99±0.12  2.54±0.15*  1.11±0.07  1.49±0.13  1.39±0.14* 
1336 
mg/ml 
 
1.22±0.10  2.88±0.32  2.11±0.17*  1.55±0.16  1.88±0.11*  1.51±0.13  1.51±0.13* 
Reference 
drug 
Aspirin  
133.5 
mg/ml 
 
 
1.45 ± 0.20 
 
 
2.65 ± 0.50 
 
 
1.80± 0.18* 
 
 
1.90± 0.20* 
 
 
1.73± 0.35* 
 
 
1.70± 0.40* 
 
 
1.60± 0.42* 
 
 
  Reaction time (sec) 
Treatme
nt  Dose 
Pre 
treatment  Post treatment 
     
1
st hour  2
nd hour  3
rd hour  4
th hour  5
th hour  6
th hour 
 
Control 
 
2ml water  
 
10.70±0.89 
 
10.19±1.07 
 
10.37±1.13 
 
10.80±0.72 
 
10.60±0.67 
 
11.30±0.40 
 
11.95±0.63 
BTB  84 mg/ml  
 
8.77±0.72  10.61±0.29  11.25±0.50  11.83±0.96  9.36±0.67  8.66±0.92  7.95±0.53 
  167  mg/ml  
 
10.73±0.54  9.72±0.52  8.14±0.67  7.87±0. 63  8.07±0.85  9.58±0.54  11.44±0.46 
  501 mg/ml  
 
11.67±0.35  13.28±1.01*  14.26±0.93*  10.53±0.91  9.37±0.92  10.63±1.20  10.81±0.83 
  1336 mg/ml  
 
11.25±0.77  16.08±1.79*  14.28±0.67*  13.47±0.64*  12.76±1.17
* 
11.57±1.34  11.23±1.24 
Aspirin 
 
133.5 mg/ml  11.90± 1.10  17.45 ± 2.26*  16.59 ± 0.68*  16.02 ± 2.30*  14.52±1.01
* 
11.98±0.83  11.66±1.09 Ratnasooriya Wanigasekara Daya et al. IRJP 2 (6) 2011 128-137 
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Table 3:  Effect of oral administration of Sri Lankan high grown Dust grade black tea brew (Camellia sinensis)  on antinociceptive parameters of formalin test in rats 
(mean ±SEM) 
*P< 0.05 compared to control (ANOVA with Turkey’s family error post hoc test); BTB= Black tea brew 
 
Table 4: The effect of oral administration of different dose of Dust grade No 1 black tea brew (Camellia sinensis) on acetic acid-induced writhing in mice (Mean ± SEM) 
 
Treatment 
 
  Number of writhing 
 
Control 
 
Water (2 ml) 
 
 
54.4 ± 0.50 
BTB  84 mg/ml 
 
50.4 ± 0.59 
  167 mg/ml 
 
47.6 ± 0.31 
  501 mg/ml 
 
35.6 ± 0.64* 
  1336 mg/ml 
 
34.2 ± 0.57* 
Reference drug  Dicolofenec (100mg/ml) 
 
4.65 ± 0.30* 
*P< 0.05 compared to control (ANOVA with Turkey’s family error post hoc test); BTB= Black tea brew 
 
Table 5: Effect of oral administration of Sri Lankan high grown Dust grade No 1 black tea brew (Camellia sinensis)   on reaction time of rats in the hot plate test 
(Mean ±SEM) 
*P< 0.05 compared to control (ANOVA with Turkey’s family error post hoc test); BTB= Black tea brew 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment  Early phase 
(0-5min) 
Late phase 
(20-60 min) 
 
Number of 
flinching 
Number of 
lifting 
Number of 
Licking 
Licking 
duration 
(sec) 
Lifting 
duration 
(sec) 
Number of 
flinching 
Number 
of lifting 
Number of 
Licking 
Licking 
duration 
(sec) 
Lifting 
duration 
(sec) 
Control  58.0 ± 0.85  10.0 ± 0.38  21.0 ± 0.58  1.2 ± 0.85  3.8 ± 0.56  75.0 ± 0.96  28.0 ± 
0.58 
74.5 ± 2.58  4.1± 1.03  4.5 ± 0.35 
BTB                     
84 mg/ml  55.3 ± 0.62  8.2 ± 0.32  19.0 ± 0.46  0.9 ± 0.04  3.5 ± 0.02  72.5 ± 0.55  26.3 ± 
0.52 
74.0 ± 0.32  3.5 ± 0.03  4.4 ± 0.04 
167 mg/ml  50.2 ± 0.58  7.7 ± 0.22  16.1± 0.26  0.7 ± 0.03  3.4 ± 0.01  68.8±0.43  23.2 ± 
0.48 
73.1 ± 0.52  3.4 ± 0.04  4.2 ± 0.02 
501 mg/ml 
 
49.0 ± 6.19  10.6 ± 0.79  17.0 ± 0.80  1.1 ± 0.03  3.8 ± 0.33  31.4 ± 
4.14* 
18.4 ± 
0.24* 
65.2 ± 4.04*  2.1 ± 1.38*  3.7 ± 0.50* 
Reference Drug 
Aspirin  133.5 
mg/ml 
 
58.9 ± 0.25 
 
12.8 ± 0.28 
 
23.0 ± 0.52 
 
1.8 ± 0.07 
 
4.1 ± 0.38 
 
20.8 ± 2.3* 
 
15.8 ± 
0.3* 
 
52.3 ± 5.2* 
 
2.0 ± 0.5* 
 
3.8 ± 0.2* 
      Reaction time (sec)     
Treatment  Pre treatment      Post treatment       
   
1
st hour  2
nd hour  3
rd hour  4
th hour  5
th hour  6
th hour 
Control  (water)  11.35±0.12  10.83±0.28  10.24±0.31  9.24±0.17  11.01±0.22  10.35±0.11  10.43±0.17 
BTB               
84 mg/ml 
 
11.74±10.20  14.34±0.29*  14.34±10.29*  11.36±0.18*  10.15±0.24  10.07±0.25  10.90±0.21 
167 mg/ml 
 
12.01±0.12  12.91±0.20*  12.54±0.28*  11.01±0.18*  10.31±0.18  10.57±0.21  9.97±0.19 
501 mg/ml 
 
11.24±0.43  12.70±0.17*  11.27±0.13  10.98±0.07  10.41±0.09  10.27±0.19  10.37±0.23 Ratnasooriya Wanigasekara Daya et al. IRJP 2 (6) 2011 128-137 
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Table 6: In vitro antioxidant activity of Sri Lankan high grown Dust grade No :1 black brew of Camellia sinensis as determine by DPPH assay 
(means ± SEM). 
 
 
Tea sample 
 
 
Antioxidant activity (Trolox equivalents µg/l) 
 
Black Tea Brew 
Low concentration (83 mg/ml) 
 
 
2985 ± 6.0 
 
Mid concentration (169 mg/ml) 
 
3572 ± 86.5 
 
High concentration (501 mg/ml) 
 
 
3923 ± 6.5 
DPPH = 1-1-diphenyl-2-picrylbhydrazyl 
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